We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Association Between Rosacea and Parkinson Disease

Alice He, BS1; Ronald J. Sweren, MD1; Shawn G. Kwatra, MD1
[+] Author Affiliations
1Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland
JAMA Neurol. 2016;73(9):1158-1159. doi:10.1001/jamaneurol.2016.1875.
Text Size: A A A
Published online


To the Editor The study by Egeberg et al1 in JAMA Neurology found that rosacea is an independent risk factor for Parkinson disease. This is an interesting finding; however, from an etiologic standpoint, we feel it is important to take into account that rosacea is a diverse condition with several subtypes. The National Rosacea Society Expert Committee2 recognizes the following 4 subtypes of rosacea: erythematotelangiectatic, inflammatory papulopustular, phymatous, and ocular. Patients with each subtype have varying demographics, clinical symptoms, and underlying pathomechanisms. While the authors in this study performed a sensitivity analysis on patients with the ocular subtype,1 they did not differentiate among the other 3 types of rosacea.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





September 1, 2016
Athanasia Alexoudi, MD, MsC, PhD; Iliana Alexoudi, MD; Stylianos Gatzonis, MD, PhD
1Department of Neurosurgery, University of Athens Medical School, Evangelismos Hospital, Athens, Greece
2Department of Dermatology, Royal Free Hospital, London, England
JAMA Neurol. 2016;73(9):1159. doi:10.1001/jamaneurol.2016.2321.
September 1, 2016
Alexander Egeberg, MD, PhD; Jacob P. Thyssen, MD, PhD, DMSci
1Department of Dermatology and Allergy, Herlev and Gentofte University Hospital, University of Copenhagen, Hellerup, Denmark
JAMA Neurol. 2016;73(9):1159-1160. doi:10.1001/jamaneurol.2016.1864.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...